Skip to main content
Premium Trial:

Request an Annual Quote

Adarza BioSystems Raises $6.8M in Series A Round

NEW YORK (GenomeWeb) – Adarza BioSystems has closed the final tranche of a Series A round of financing that brought in a total of $6.8 million.

The West Henrietta, NY-based firm has developed a label-free, multiplex biosensor platform based on its Arrayed Imaging Reflectometry technology. According to the firm, the platform can rapidly identify and quantify a series of biological target analyte species in a fluid sample without the use of chemical labels.

The firm said it would use proceeds from the Series A round to launch its first 100-plex immunoassay consumable and instrument and accelerate the development of higher-plex assays for a variety of biological analytes. It didn't disclose the targets of the immunoassay product.

The firm previously received two SBIR grants from the National Institutes of Health to develop antibody arrays for detecting protein biomarkers that may indicate early cancer and for monitoring the levels of proteins linked to potentially toxic environmental exposures.

The financing round was led by Cultivation Capital Life Science Fund and the venture capital unit of Siemens.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.